I think the right bit of news and it will smash through 17.5 cents.
SCE haven't done an update on last OXY trial and KINGS sale at $3.6 Billion to Pfizer.
Even at a discounted valuation of just 10 percent that is still 50 cents per share. Just for OXY and Morphein.
They already from last update have a 49 cents to $1.03 valuation.
The results of the OXY trial and the KING deal add much weight.
PoS
another run at 17.5, page-16
-
- There are more pages in this discussion • 52 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
-0.001(33.3%) |
Mkt cap ! $6.338M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.2¢ | $2.565K | 874.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 29 | 40547400 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 39021116 | 27 |
View Market Depth
| Last trade - 15.59pm 12/11/2024 (20 minute delay) ? |
| AVE (ASX) Chart |